Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Orthopediatrics (KIDS) Share-based Compensation (2016 - 2025)

Orthopediatrics (KIDS) has disclosed Share-based Compensation for 10 consecutive years, with $4.4 million as the latest value for Q4 2025.

  • On a quarterly basis, Share-based Compensation rose 13.58% to $4.4 million in Q4 2025 year-over-year; TTM through Dec 2025 was $17.8 million, a 31.22% increase, with the full-year FY2025 number at $17.8 million, up 31.22% from a year prior.
  • Share-based Compensation was $4.4 million for Q4 2025 at Orthopediatrics, up from $4.3 million in the prior quarter.
  • In the past five years, Share-based Compensation ranged from a high of $5.3 million in Q2 2025 to a low of $1.3 million in Q1 2021.
  • A 5-year average of $2.7 million and a median of $2.6 million in 2023 define the central range for Share-based Compensation.
  • Peak YoY movement for Share-based Compensation: tumbled 43.29% in 2021, then skyrocketed 86.55% in 2023.
  • Orthopediatrics' Share-based Compensation stood at $1.7 million in 2021, then increased by 1.73% to $1.7 million in 2022, then skyrocketed by 61.49% to $2.7 million in 2023, then surged by 41.54% to $3.9 million in 2024, then grew by 13.58% to $4.4 million in 2025.
  • Per Business Quant, the three most recent readings for KIDS's Share-based Compensation are $4.4 million (Q4 2025), $4.3 million (Q3 2025), and $5.3 million (Q2 2025).